AMGN vs DGICB · P/E 24, rev $10.05B vs P/E 10, rev $978.0M
Amgen Inc (AMGN) versus Donegal Group B Inc (DGICB) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Donegal Group B Inc (DGICB) is a insurance - property & casualty company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported DGICB revenue for 2025-12-31 was $978.0M. Net income was $79.3M. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. DGICB currently screens at market cap $677.6M and trailing P/E 10.3.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. DGICB currently screens at market cap $677.6M and trailing P/E 10.3.
Not investment advice. Open the AMGN and DGICB stock pages for the full models.
Not investment advice.